Real-world outcomes of first-line pembrolizumab plus chemotherapy in metastatic triple-negative breast cancer with central nervous system metastases: a multicenter cohort from Poland, the Czech Republic and Slovakia

Reports of Practical Oncology and Radiotherapy · Published 2026-08-03 · DOI 10.5603/rpor.113778

Free full text

Authors (13)

Małgorzata Pieniążek, Miloš Holánek, Katarzyna Świderska, Bartosz Gąsior, Joanna Kiszka, Aleksandra Konieczna, Anika Pękala, Lenka Rušinová, Zuzana Bielčiková, Michał Jarząb, Aleksandra Łacko, Renata Pacholczak-Madej, Mirosława Püsküllüoğlu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Pieniążek, M., Holánek, M., Świderska, K., et al. (2026). Real-world outcomes of first-line pembrolizumab plus chemotherapy in metastatic triple-negative breast cancer with central nervous system metastases: a multicenter cohort from Poland, the Czech Republic and Slovakia. Reports of Practical Oncology and Radiotherapy. https://doi.org/10.5603/rpor.113778

Related articles